EMJ Dermatology [Supplement 2] . 2022

In this issue

Presentations from the Virtual 30th European Academy of Dermatology and Venereology (EADV) Congress 2021 discussed the potential of targeting the IL-23 pathway as a biologic treatment for psoriatic arthritis (PsA) and psoriasis (PsO).

Rate this content's potential impact on patient outcomes

Average rating / 5. Vote count:

No votes so far! Be the first to rate this content.